pharma-company /Medicinal products /Active ingredients

Rx · PZN 11182837

BLINCYTO 38,5 µg powder for a concentrate and solution for preparation of an infusion L

German trade nameBLINCYTO 38,5 -m63g Pulver für einer Konzentrat und Lösung zur Herstellung einer Infusionslösung

Active ingredientBlinatumomab

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Highest known
purchase price (B2B)

~ €2,246

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for BLINCYTO 38,5 µg powder for a concentrate and solution for preparation of an infusion L.

Review purchasing terms

BLINCYTO 38,5 µg powder for a concentrate and solution for preparation of an infusion L contains the active ingredient Blinatumomab. One pack size is recorded (PZN 11182837). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability.


BLINCYTO 38,5 µg powder for a concentrate and solution for preparation of an infusion L was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.